GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Guru Stocks at 52-Week Lows: Abbott Laboratories, Celgene Corp, Accenture Ltd, Harris Corp, and McCormick & Company Inc

April 18, 2009 | About:
Saj Karsan

The market was up 1.6% last week, and the market has been up for about a month now. The number of 52-week low companies have also greatly decreased. Last week's top five stocks that reached their 52-week lows were Abbott Laboratories, Celgene Corp, Accenture Ltd, Harris Corp, and McCormick & Company Inc. According to GuruFocus updates, these Guru stocks have reached their 52-week lows.

Over the past few weeks, the stocks who have reached their 52-week lows have decreased dramatically, and the number of out of favor industries have also decreased. Last week's top two out of favor industries were the Industrial Goods and Services and Food and Beverage industries. 8 Industrial Goods and Services companies have reached their 52-week lows, while 6 have reached their 52-week high, giving the industry a low/high of 1.33. In the Food and Beverage industry, 2 stocks have reached their 52-week lows, while 2 have reached their 52-week highs, giving the industry a low/high ratio of 1.

For full details about guru stocks at 52-week lows, click here: http://www.gurufocus.com/52weeklow.php.

Abbott Laboratories (ABT) Reached the 52-Week Low of $43.89

The prices of Abbott Laboratories (ABT) shares have declined to close to the 52-week low of $43.89, which is 28.7% off the 52-week high of $59.81. Abbott Laboratories is owned by 9 Gurus we are tracking. Among them, 2 have added to their positions during the past quarter. 5 reduced their positions.

Abbott Laboratories is a global broad-based health care company devoted to discovering new medicines new technologies and new ways to manage health. The company has a market cap of $67.83 billion; its shares were traded at around $43.89 with a P/E ratio of 13.3 and P/S ratio of 2.3. The dividend yield of Abbott Laboratories stocks is 3.3%. Abbott Laboratories had an annual average earning growth of 4.4% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 5-star.

Abbott Labs recently reported its first quarter 2009 results. The company said that its earnings rose 16%, The company also reported that it increased its dividend for the quarter by 11%, compared to the company's dividend of last quarter. The company Confirmed its Double-Digit EPS Guidance Range for 2009.

Ken Heebner owns 9,335,000 shares as of 12/31/2008, an increase of 18.16% from the previous quarter. This position accounts for 7.26% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Robert Bruce owns 81,745 shares as of 12/31/2008, which accounts for 5.97% of the $72 million portfolio of Bruce & Co., Inc.. Edward Owens owns 13,300,000 shares as of 12/31/2008, which accounts for 4.03% of the $17.62 billion portfolio of Vanguard Health Care Fund. Kenneth Fisher owns 15,221 shares as of 12/31/2008, a decrease of 37.71% of from the previous quarter. Brian Rogers sold out his holdings in the quarter that ended on 12/31/2008.

Sell: Chairman and CEO Miles D White sold 150,000 shares of ABT stock on 03/16/2009 at the average price of $47.5; the price of the stock has decreased by 7.6% since.

Celgene Corp. (CELG) Reached the 52-Week Low of $38.3

The prices of Celgene Corp. (CELG) shares have declined to close to the 52-week low of $38.3, which is 50.3% off the 52-week high of $77.01. Celgene Corp. is owned by 4 Gurus we are tracking. Among them, 2 have added to their positions during the past quarter. 1 reduced his position.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery development and commercialization of orally administered small molecule drugs for the treatment of cancer and immunological diseases. Celgene Corp. has a market cap of $17.6 billion; its shares were traded at around $38.3 with a P/E ratio of 27.8 and P/S ratio of 7.7.

Celgene Corp. recently reported its fourth quarter and full year 2008 results. The company announced that its non-GAAP total revenue increased over 50%, to $623 Million, while the company's GAAP Total Revenue was $628 Million for the fourth quarter of 2008. Full year total revenue was $2.2 billion, rising 59% compared to the full year revenue of 2007.

Ken Heebner bought 1,900,000 shares in the quarter that ended on 12/31/2008, which is 1.53% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Kenneth Fisher owns 321,286 shares as of 12/31/2008, which accounts for 0.08% of the $20.33 billion portfolio of Fisher Asset Management, LLC. David Swensen owns 6,292 shares as of 12/31/2008, which accounts for 0.38% of the $91 million portfolio of Yale University. Kenneth Fisher owns 320,610 shares as of 03/31/2009, which accounts for 0.07% of the $20.33 billion portfolio of Fisher Asset Management, LLC.

Sell: CEO, Director Sol J Barer sold 250,388 shares of CELG stock on 10/30/2008 at the average price of $63.38; the price of the stock has decreased by 39.57% since.

Sell: CFO David W Gryska sold 23,264 shares of CELG stock on 11/03/2008 at the average price of $64.5; the price of the stock has decreased by 40.62% since.

Accenture Ltd (ACN) Reached the 52-Week Low of $27.12

The prices of Accenture Ltd (ACN) shares have declined to close to the 52-week low of $27.12, which is 36.3% off the 52-week high of $41.96. Accenture Ltd is owned by 3 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 3 reduced their positions.

Accenture is the world's leading provider of management and technology consulting services and solutions. The company has a market cap of $16.62 billion; its shares were traded at around $27.12 with a P/E ratio of 9.8 and P/S ratio of 0.7. The dividend yield of Accenture Ltd stocks is 1.8%. Accenture Ltd had an annual average earning growth of 23.4% over the past 5 years.

ACN recently filed its Quarterly Report for the period ended 2009-02-28. Net revenues for the three and six months ended February 28, 2009 were $3.03 billion and $6.69 billion respectively, compared to $3.35 billion and $6.81 billion, respectively, for the three and six months ended February 29, 2008. This decline was caused by less demand since January of 2009.

Tom Gayner owns 121,600 shares as of 12/31/2008, which accounts for 0.35% of the $1.13 billion portfolio of Markel Gayner Asset Management Corp. PRIMECAP Management owns 4,867,881 shares as of 12/31/2008, which accounts for 0.37% of the $43.42 billion portfolio of PRIMECAP Management. John Rogers owns 2,656,577 shares as of 12/31/2008, which accounts for 2.1% of the $4.14 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC. Joel Greenblatt sold out his holdings in the quarter that ended on 12/31/2008.

Sell: Director Dennis F Hightower sold 5,840 shares of ACN stock on 03/31/2009 at the average price of $27.77; the price of the stock has decreased by 2.34% since.

Harris Corp. (HRS) Reached the 52-Week Low of $28.78

The prices of Harris Corp. (HRS) shares have declined to close to the 52-week low of $28.78, which is 57.6% off the 52-week high of $65.78. Harris Corp. is owned by 6 Gurus we are tracking. Among them, 4 have added to their positions during the past quarter. 1 reduced hiss position.

Harris Corporation is an international company focused on communications equipment for voice data and video applications. The company has a market cap of $3.85 billion; its shares were traded at around $28.78 with a P/E ratio of 7.9 and P/S ratio of 0.8. The dividend yield of Harris Corp. stocks is 2.7%. Harris Corp. had an annual average earning growth of 21.3% over the past 10 years.

Harris Corp. recently reported its second quarter results. The company also announced that it would report its third quarter results on May 5 th, 2009. The company reported revenue of $1.52 billion in its second quarter of fiscal 2009, an increase of 16 percent compared to $1.32 billion in the prior-year quarter.

Michael Price bought 12,300 shares in the quarter that ended on 12/31/2008, which is 0.23% of the $206 million portfolio of MFP Investors LLC. Kenneth Fisher owns 52,475 shares as of 12/31/2008, an increase of 13.4% from the previous quarter. This position accounts for 0.01% of the $20.33 billion portfolio of Fisher Asset Management, LLC. Ronald Muhlenkamp owns 585,518 shares as of 12/31/2008, which accounts for 3.53% of the $631 million portfolio of Muhlenkamp Fund.

Sell: President - BCD Timothy E Thorsteinson sold 8,000 shares of HRS stock on 02/19/2009 at the average price of $39.98; the price of the stock has decreased by 28.01% since.

McCormick & Company Inc. (MKC) Reached the 52-Week Low of $29.06

The prices of McCormick & Company Inc. (MKC) shares have declined to close to the 52-week low of $29.06, which is 32.0% off the 52-week high of $41.97. McCormick & Company Inc. is owned by 3 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 1 reduced their positions.

McCormick & Company a diversified specialty food company is a global leader in the manufacture marketing and distribution of spices to the entire food industry. McCormick & Company Inc. has a market cap of $3.78 billion; its shares were traded at around $29.06 with a P/E ratio of 13.4 and P/S ratio of 1.2. The dividend yield of McCormick & Company Inc. stocks is 3.3%. McCormick & Company Inc. had an annual average earning growth of 10.1% over the past 10 years. GuruFocus rated McCormick & Company Inc. the business predictability rank of 5-star.

Alcoa Inc. recently reported its results for fourth quarter 2008. The company said that its net income was a loss of $1.19 billion, compared to a gain in net income for the fourth quarter 2007, which was $632 million. Revenues for the fourth quarter 2008 were $5.7 billion, down from $7.0 billion in the third quarter 2008 and $6.1 billion in the fourth quarter 2007 after excluding divested businesses.

John Hussman bought 750,000 shares in the quarter that ended on 12/31/2008, which is 0.71% of the $3.37 billion portfolio of Hussman Economtrics Advisors, Inc.. Brian Rogers owns 2,000,000 shares as of 12/31/2008, which accounts for 0.47% of the $13.49 billion portfolio of T Rowe Price Equity Income Fund. Mark Hillman owns 23,246 shares as of 12/31/2008, a decrease of 25.03% of from the previous quarter. This position accounts for 0.24% of the $308 million portfolio of Hillman Capital Management.

Buy: President - Europe, Middle Lawrence Erik Kurzius bought 2,500 shares of MKC stock on 04/03/2009 at the average price of $29.3; the price of the stock has decreased by 0.82% since.

Go here for the complete list of 52-week lows.

Rating: 3.1/5 (10 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK